Hi-Tech gets approval on prescription dermatitis treatment, will launch Tropazone in February
By APThursday, January 7, 2010
Hi-Tech Pharmacal says FDA clears Tropazone lotion
AMITYVILLE, N.Y. — Hi-Tech Pharmacal Co. said Thursday it received marketing approval for a prescription lotion called Tropazone for dermatitis — or skin rash.
The company said the Food and Drug Administration cleared Tropazone, and it plans to start marketing the drug in February.
Tropazone is intended to treat atopic dermatitis, allergic contact dermatitis and radiation dermatitis, among other conditions.
It will be marketed by Hi-Tech’s ECR subsidiary starting in February. In morning trading, Hi-Tech shares rose 93 cents, or 3.3 percent, to $29.42.
Tags: Amityville, Diseases And Conditions, Medical Technology, Skin Disorders
|
April 26, 2010: 12:24 am
For those who are interested more.. it soothe the burning and itching of the skin and main ingredients are Purified water,liquid paraffin (mineral oil),petrolatum,alcohol, glyceryl stearate,PEG-100 stearate, paraffin, lecithin, polysorbate 60, DEA-Cetyl phosphate, dimethicone, carbomer,imidazolidinyl urea,methylparaben,propylparaben,triethanolamine and fragrance |
|
February 14, 2010: 3:27 pm
Software outsourcer Tech Mahindra will provide telecom operator Etisalat DB with IT solutions and infrastructure requirements for its proposed services rollout in 15 telecom circles, it was announced here Monday. |
Skin Care Advice